Stocks and Investing Stocks and Investing
Mon, March 7, 2022

Madhu Kumar Maintained (APLS) at Strong Buy with Decreased Target to $86 on, Mar 7th, 2022


Published on 2024-10-27 19:58:46 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of Goldman Sachs, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Decreased Target from $102 to $86 on, Mar 7th, 2022.

Madhu has made no other calls on APLS in the last 4 months.



There are 5 other peers that have a rating on APLS. Out of the 5 peers that are also analyzing APLS, 1 agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Monday, November 29th, 2021


These are the ratings of the 4 analyists that currently disagree with Madhu


  • Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $112 on, Tuesday, January 11th, 2022
  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $84 on, Wednesday, December 8th, 2021
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $72 on, Wednesday, November 24th, 2021

Contributing Sources